NO870075L - Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.Info
- Publication number
- NO870075L NO870075L NO870075A NO870075A NO870075L NO 870075 L NO870075 L NO 870075L NO 870075 A NO870075 A NO 870075A NO 870075 A NO870075 A NO 870075A NO 870075 L NO870075 L NO 870075L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- therapeutic active
- indol derivatives
- indol
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868600397A GB8600397D0 (en) | 1986-01-08 | 1986-01-08 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO870075D0 NO870075D0 (no) | 1987-01-08 |
| NO870075L true NO870075L (no) | 1987-07-09 |
Family
ID=10591074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO870075A NO870075L (no) | 1986-01-08 | 1987-01-08 | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4855314A (https=) |
| EP (1) | EP0240096A1 (https=) |
| JP (1) | JPS62228056A (https=) |
| KR (1) | KR870007116A (https=) |
| CN (1) | CN1030409A (https=) |
| AU (1) | AU597325B2 (https=) |
| BE (1) | BE1000071A4 (https=) |
| CH (1) | CH672637A5 (https=) |
| DE (1) | DE3700408A1 (https=) |
| DK (1) | DK8787A (https=) |
| FI (1) | FI870062A7 (https=) |
| FR (1) | FR2595351B1 (https=) |
| GB (2) | GB8600397D0 (https=) |
| HU (1) | HU198685B (https=) |
| IL (1) | IL81201A (https=) |
| IT (1) | IT1205849B (https=) |
| LU (1) | LU86732A1 (https=) |
| NL (1) | NL8700026A (https=) |
| NO (1) | NO870075L (https=) |
| NZ (1) | NZ218868A (https=) |
| PH (1) | PH24741A (https=) |
| PT (1) | PT84075B (https=) |
| ZA (1) | ZA87105B (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8530507D0 (en) * | 1985-12-11 | 1986-01-22 | Glaxo Group Plc | Chemical compounds |
| GB8600398D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
| US5225431A (en) * | 1987-10-23 | 1993-07-06 | Burroughs Wellcome Co. | Therapeutic substituted indole compounds and compositions thereof |
| GB8724912D0 (en) | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| GB8819024D0 (en) * | 1988-08-10 | 1988-09-14 | Glaxo Group Ltd | Chemical compounds |
| GB8823731D0 (en) * | 1988-10-10 | 1988-11-16 | Smith Kline French Lab | Biologically active compounds |
| PT97888B (pt) * | 1990-06-07 | 1998-12-31 | Zeneca Ltd | Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| PL170330B1 (pl) * | 1990-10-15 | 1996-11-29 | Pfizer | Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL |
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
| HUT69705A (en) * | 1991-11-25 | 1995-09-28 | Pfizer | Indole derivatives |
| TW288010B (https=) * | 1992-03-05 | 1996-10-11 | Pfizer | |
| US5747501A (en) | 1992-04-07 | 1998-05-05 | Pfizer, Inc. | Indole derivatives |
| US6380233B1 (en) | 1992-04-07 | 2002-04-30 | Pfizer Inc | Indole derivatives as 5-HT1 agonists |
| GB9207930D0 (en) * | 1992-04-10 | 1992-05-27 | Pfizer Ltd | Indoles |
| NZ251047A (en) * | 1992-04-10 | 1996-09-25 | Pfizer | Acylaminoindole derivatives and medicaments |
| GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
| TW251284B (https=) * | 1992-11-02 | 1995-07-11 | Pfizer | |
| FR2707639B1 (fr) * | 1993-06-30 | 1995-10-13 | Pf Medicament | Nouveaux composés indoliques dérivés d'arylamines comme ligands sélectifs des récepteurs 5HT1D et 5HT1B. |
| ES2070772B1 (es) * | 1993-08-09 | 1996-02-16 | Pfizer | Derivados de acilaminoindol |
| KR100191973B1 (ko) * | 1993-08-31 | 1999-06-15 | 디. 제이. 우드, 스피겔 알렌 제이 | 5-아릴인돌 유도체 |
| US5468768A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antimigraine derivatives of indolylcycloalkanylamines |
| GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| FR2749846B1 (fr) * | 1996-06-17 | 1998-09-11 | Pf Medicament | Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| ATE328868T1 (de) * | 2000-08-21 | 2006-06-15 | Pacific Corp | Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten |
| ES2276109T3 (es) | 2002-06-21 | 2007-06-16 | Suven Life Sciences Limited | Nuevos indoles arilcarbonilicos tetraciclicos que tienen afinidad por el receptor de serotonina, utiles como agentes terapeuticos, proceso para su preparacion y mezclas farmaceuticas que los contienen. |
| DK1523486T3 (da) * | 2002-06-21 | 2008-03-03 | Suven Life Sciences Ltd | Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet |
| DE60329607D1 (de) * | 2002-06-21 | 2009-11-19 | Suven Life Sciences Ltd | Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten |
| MXPA05005700A (es) | 2002-11-28 | 2005-08-16 | Suven Life Sciences Ltd | N-arilsulfonil-3-aminoalcoxiindoles. |
| JP4559230B2 (ja) * | 2002-11-28 | 2010-10-06 | スベン ライフ サイエンシズ リミティド | セロトニン受容体に対する親和性を有する新規ｎ−アリールスルホニル−３−置換されたインドール、その調製方法、それを含有する医薬組成物 |
| EA009367B1 (ru) * | 2002-12-18 | 2007-12-28 | Сувен Лайф Сайенсиз Лимитед | ПРОИЗВОДНЫЕ 5-ТИА-5-ДИОКСО-4b-АЗАИНДЕНО[2,1-a]ИНДЕНА, ОБЛАДАЮЩИЕ АФФИННОСТЬЮ К РЕЦЕПТОРУ СЕРОТОНИНА |
| US7645886B2 (en) * | 2002-12-20 | 2010-01-12 | Ciba Specialty Corporation | Synthesis of amines and intermediates for the synthesis thereof |
| RU2008151724A (ru) * | 2006-06-12 | 2010-07-20 | Новартис АГ (CH) | Способ получения солей n-гидрокси-3-[4-[[[2-(2-метил-1н-индол-3-ил)этил]амино]метил]фенил]-2е-2-пропенамида |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3472870A (en) * | 1966-08-29 | 1969-10-14 | Mead Johnson & Co | Sulfonamidotryptamines |
| FR2334358A1 (fr) * | 1975-12-12 | 1977-07-08 | Sogeras | Nouveaux medicaments derives de l'indole |
| ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
| SE454777B (sv) * | 1980-08-12 | 1988-05-30 | Glaxo Group Ltd | 5-substituerade 3-aminoalkyl-1h-indoler, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren |
| ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
| GB8332435D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| GB8332434D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Production of chemical compounds |
| GB8600398D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
-
1986
- 1986-01-08 GB GB868600397A patent/GB8600397D0/en active Pending
-
1987
- 1987-01-08 LU LU86732A patent/LU86732A1/fr unknown
- 1987-01-08 NZ NZ218868A patent/NZ218868A/xx unknown
- 1987-01-08 FI FI870062A patent/FI870062A7/fi not_active Application Discontinuation
- 1987-01-08 IL IL81201A patent/IL81201A/xx unknown
- 1987-01-08 NO NO870075A patent/NO870075L/no unknown
- 1987-01-08 DE DE19873700408 patent/DE3700408A1/de not_active Withdrawn
- 1987-01-08 DK DK008787A patent/DK8787A/da unknown
- 1987-01-08 GB GB8700382A patent/GB2185020B/en not_active Expired - Fee Related
- 1987-01-08 US US07/001,469 patent/US4855314A/en not_active Expired - Lifetime
- 1987-01-08 AU AU67420/87A patent/AU597325B2/en not_active Ceased
- 1987-01-08 FR FR878700107A patent/FR2595351B1/fr not_active Expired - Fee Related
- 1987-01-08 EP EP87300166A patent/EP0240096A1/en not_active Withdrawn
- 1987-01-08 CH CH45/87A patent/CH672637A5/fr not_active IP Right Cessation
- 1987-01-08 PH PH34698A patent/PH24741A/en unknown
- 1987-01-08 ZA ZA87105A patent/ZA87105B/xx unknown
- 1987-01-08 KR KR870000068A patent/KR870007116A/ko not_active Withdrawn
- 1987-01-08 NL NL8700026A patent/NL8700026A/nl not_active Application Discontinuation
- 1987-01-08 BE BE8700003A patent/BE1000071A4/fr not_active IP Right Cessation
- 1987-01-08 JP JP62002589A patent/JPS62228056A/ja active Pending
- 1987-01-08 IT IT47507/87A patent/IT1205849B/it active
- 1987-01-08 PT PT84075A patent/PT84075B/pt not_active IP Right Cessation
- 1987-07-03 HU HU873020A patent/HU198685B/hu not_active IP Right Cessation
- 1987-07-06 CN CN87105335A patent/CN1030409A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT8747507A0 (it) | 1987-01-08 |
| KR870007116A (ko) | 1987-08-14 |
| AU6742087A (en) | 1987-07-09 |
| PT84075A (en) | 1987-02-01 |
| DK8787D0 (da) | 1987-01-08 |
| GB2185020A (en) | 1987-07-08 |
| US4855314A (en) | 1989-08-08 |
| DE3700408A1 (de) | 1987-07-09 |
| IT1205849B (it) | 1989-03-31 |
| FR2595351B1 (fr) | 1990-07-13 |
| FR2595351A1 (fr) | 1987-09-11 |
| FI870062A0 (fi) | 1987-01-08 |
| NO870075D0 (no) | 1987-01-08 |
| CN1030409A (zh) | 1989-01-18 |
| IL81201A (en) | 1991-06-10 |
| PH24741A (en) | 1990-10-01 |
| GB8700382D0 (en) | 1987-02-11 |
| GB2185020B (en) | 1990-05-16 |
| ZA87105B (en) | 1987-09-30 |
| HU198685B (en) | 1989-11-28 |
| IL81201A0 (en) | 1987-08-31 |
| BE1000071A4 (fr) | 1988-02-02 |
| GB8600397D0 (en) | 1986-02-12 |
| FI870062A7 (fi) | 1987-07-09 |
| HUT46891A (en) | 1988-12-28 |
| NL8700026A (nl) | 1987-08-03 |
| JPS62228056A (ja) | 1987-10-06 |
| LU86732A1 (fr) | 1988-02-02 |
| PT84075B (pt) | 1989-07-31 |
| CH672637A5 (https=) | 1989-12-15 |
| NZ218868A (en) | 1990-04-26 |
| DK8787A (da) | 1987-07-09 |
| AU597325B2 (en) | 1990-05-31 |
| EP0240096A1 (en) | 1987-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO870075L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO853046L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO871267L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
| NO871588L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. | |
| NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
| NO863671D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. | |
| NO864131D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater. | |
| NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO871044D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO884175D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO864101L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
| NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. |